Plus   Neg

Stock Alert: Eastman Kodak Surges 79%

Shares of Eastman Kodak Co. (KODK) are surging almost 79 percent or $4.92 in Wednesday's morning trade at $11.15.

Akin Gump Strauss Hauer & Feld LLP, a law firm hired by a special committee of the company's board, has concluded in a report that securities transactions made by the company's chief executive Jim Continenza did not violate internal policies or the securities regulations as well as other relevant laws.

The transactions by Continenza were made around the time the company learned it could a receive a $765 million government loan.

Shares of Eastman Kodak had tumbled last week on news that the U.S. International Development Finance Corp. is halting the $765 million loan to the company to enter into generic drug manufacturing amid allegations of insider trading.

Eastman Kodak has traded in a range of $1.50 to $60.00 in the past 52 weeks.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
U.S. tech giant Google is laying the groundwork for a fiber-optic network that will connect the first time through Saudi Arabia and Israel, opening a new global internet traffic corridor, the Wall Street Journal reported, citing people familiar with the plans. The link would be established as part of an optical-fiber cable line connecting Europe with India. U.S. retailers Best Buy Co. Inc., Abercrombie & Fitch Co., and Dollar Tree Inc. on Tuesday reported results for the third quarter that surpassed analysts' expectations. The upbeat results indicate that retailers have largely recovered from the impact of the coronavirus pandemic just as the holiday season approaches. The companies have also intensified their focused on digital sales. The U.S. Food and Drug Administration approved the first drug to treat primary hyperoxaluria type 1 (PH1), an ultra-rare genetic disorder which causes recurrent kidney stones and loss of kidney function. Alnylam Pharmaceuticals' Oxlumo (lumasiran) in the form of injection lowers urinary oxalate levels in pediatric and adult patients.
Follow RTT